Freyja develops minimally invasive surgical devices that integrate high‑definition video into the entry point of laparoscopic procedures. Its flagship product, VereSee™, is a 2 mm abdominal‑access device that provides real‑time visualization to eliminate blind entry, improving precision and efficiency for surgeons, initially targeting women’s health applications. The company commercializes the device through direct sales and regulatory‑cleared distribution to hospitals and surgical centers.
Funding
$8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current surgical and in-office gynecological procedures may lack the safety and efficacy needed to ensure optimal outcomes for women's health. Existing standards in gynecological care may not fully empower physicians to deliver the best possible patient care.
Solution
Freyja Healthcare develops innovative medical devices designed to improve the safety and effectiveness of both surgical and in-office procedures within women's health. By focusing on unmet clinical needs, Freyja aims to provide physicians with advanced tools that enhance procedural precision and minimize patient risk. The company's solutions are engineered to raise the standard of gynecological care, ultimately leading to better patient outcomes and improved quality of life. Freyja Healthcare is committed to advancing women's health through cutting-edge technology and a deep understanding of the challenges faced by both physicians and patients.
Target Audience
The primary target audience includes gynecologists, surgeons, and other healthcare professionals specializing in women's health.
Features
- Focus on enhancing the safety profile of gynecological procedures.
- Development of medical devices for both surgical and in-office applications.
- Solutions designed to improve procedural precision and effectiveness.